MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.clim.2021.108860

Медицинская библиотека · Clinical immunology (Orlando, Fla.) · 2021

Reactogenicity of a third BNT162b2 mRNA COVID-19 vaccine among immunocompromised individuals and seniors - A nationwide survey.

Shapiro Ben David Shirley, Shamir-Stein Na'ama, Baruch Gez Sharon, Lerner Uri, Rahamim-Cohen Daniella, Ekka Zohar Anat

СтатьяНаблюдательное исследованиеПеревод в очереди

Аннотация

BACKGROUND

Since July 13, 2021, a third SARS-CoV-2 vaccine BNT162b2 was approved in Israel to immunocompromised and seniors 60 years of age or older. We aimed to evaluate vaccine's reactogenicity.

METHODS

A retrospective cohort, using electronic surveys sent to booster vaccine recipients, during July 20-August 10, 2021.

RESULTS

17,820 participated in the survey, with a response rate of 30.2%. 3195 (17.9%) were immunocompromised. Fatigue, myalgia and fever were the most frequent systemic side effects reported (19.6%, 9.2% and 8.1% respectively among immunocompromised; 21.3%, 9.9% and 9.2% respectively among seniors). 67.3% of immunocompromised and 62% of seniors reported experiencing a better or a similar response to the third dose, compared to the second.

CONCLUSIONS

Local and systemic reactions after third BNT162b2 vaccine, reported by immunocompromised and seniors, were similar to those observed following previous vaccines and mostly self-resolved. These findings may aid promoting confidence among vaccine providers and recipients.

Для цитирования: Shapiro Ben David Shirley, Shamir-Stein Na'ama, Baruch Gez Sharon, Lerner Uri, Rahamim-Cohen Daniella, Ekka Zohar Anat. Reactogenicity of a third BNT162b2 mRNA COVID-19 vaccine among immunocompromised individuals and seniors - A nationwide survey.. Clinical immunology (Orlando, Fla.). 2021. DOI: 10.1016/j.clim.2021.108860.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.